Dr. Burtness on Challenges Facing Immunotherapy in Head and Neck

Barbara Burtness, MD
Published: Monday, Aug 07, 2017



Barbara Burtness, MD, professor of medicine, Yale Cancer Center, discusses challenges regarding immunotherapy for patients with head and neck cancer.

Although immunotherapy can lead to durable responses, there are still a population of patients who do not see any responses, explains Burtness.

According to Burtness, more research needs to be conducted in an attempt to make all patients respond to immunotherapy or to determine a targeted therapy to better support the immune system.
 


Barbara Burtness, MD, professor of medicine, Yale Cancer Center, discusses challenges regarding immunotherapy for patients with head and neck cancer.

Although immunotherapy can lead to durable responses, there are still a population of patients who do not see any responses, explains Burtness.

According to Burtness, more research needs to be conducted in an attempt to make all patients respond to immunotherapy or to determine a targeted therapy to better support the immune system.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations Across Lung, Head and Neck, and Bladder CancersApr 28, 20182.0
Publication Bottom Border
Border Publication
x